RxDoctor Payments Data

Kerrian Hazley, MD

Family Medicine · Defuniak Springs, FLNPI 1689802993

Payments from drug & device makers

$398in general payments, 2019–2025

Across 27 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$87
  • Sanofi-aventis U.S. LLC$77
  • Astellas Pharma US Inc$49
  • Lilly USA, LLC$48
  • AstraZeneca$29
  • Novo Nordisk$19
  • plus $90 from 7 others

What the payments were for

  • Food & beverage$398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK5$87
Sanofi-aventis U.S. LLC5$77
Astellas Pharma US Inc3$49
Lilly USA, LLC4$48
AstraZeneca2$29
Novo Nordisk1$19
Merck1$16
Amgen1$14
Pfizer1$13
AbbVie1$12
Nalpropion Pharmaceuticals LLC1$12
Sanofi Pasteur Inc.1$11
Arbor Pharmaceuticals, Inc.1$11

How this compares

$398 in reported general payments places this provider in the 45th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$3,176
Medicare patients
78
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tresiba Flextouch U-100Insulin Degludec13$7,593
BelsomraSuvorexant11$4,564
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,625
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,471
Gabapentin58$575
Albuterol Sulfate HfaAlbuterol Sulfate20$488
Oxycodone Hcl21$437
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine12$418
Pregabalin32$403
Testosterone Cypionate11$352
Baclofen16$323
Omeprazole20$321
Famotidine12$312
Topiramate15$237
Clonazepam33$233

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckBelsomra$16$4,56411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Defuniak Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →